Femasys Inc. is a U.S.-based biomedical company focused on women's health, offering a portfolio of in-office therapeutic and diagnostic devices. Key products include FemaSeed (intratubal insemination for infertility), FemVue (fallopian tube diagnostic), FemBloc (non-surgical permanent birth control), FemChec (tubal occlusion confirmation), FemCerv (cervical cancer sampling), FemCath (selective tubal evaluation), and FemSperm (sperm preparation and analysis). Products are commercialized in the U.S. and international markets including Europe, UK, Canada, Japan, Israel, Australia, and New Zealand.
expected 2026-11-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001140361-26-012375 | EDGAR | 90K words |
| 2025-03-27 | 2024-12-31 | 0001140361-25-010598 | EDGAR | 84K words |
| 2024-03-28 | 2023-12-31 | 0001140361-24-016230 | EDGAR | 84K words |
| 2023-03-30 | 2022-12-31 | 0001140361-23-014668 | EDGAR | 83K words |
| 2022-03-24 | 2021-12-31 | 0001140361-22-011032 | EDGAR | 81K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001140361-26-033157 | EDGAR | 26K words |
| 2025-11-14 | 2025-09-30 | 0001140361-25-042308 | EDGAR | 22K words |
| 2025-08-08 | 2025-06-30 | 0001140361-25-029864 | EDGAR | 21K words |
| 2025-05-08 | 2025-03-31 | 0001140361-25-017985 | EDGAR | 15K words |
| 2024-11-12 | 2024-09-30 | 0001140361-24-046038 | EDGAR | 19K words |
| 2024-08-08 | 2024-06-30 | 0001140361-24-036299 | EDGAR | 19K words |
| 2024-05-09 | 2024-03-31 | 0001140361-24-025068 | EDGAR | 15K words |
| 2023-11-14 | 2023-09-30 | 0001140361-23-053090 | EDGAR | 17K words |
| 2023-08-10 | 2023-06-30 | 0001140361-23-038918 | EDGAR | 17K words |
| 2023-05-11 | 2023-03-31 | 0001140361-23-024144 | EDGAR | 13K words |
| 2022-11-10 | 2022-09-30 | 0001140361-22-040812 | EDGAR | 16K words |
| 2022-08-10 | 2022-06-30 | 0001140361-22-029076 | EDGAR | 16K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-14 | 0001140361-26-033145 | EDGAR | 3K words |
| 2026-08-11 | 0001140361-26-032247 | EDGAR | 24K words |
| 2026-04-01 | 0001140361-26-012538 | EDGAR | 9K words |
| 2026-03-31 | 0001140361-26-012346 | EDGAR | 3K words |
| 2026-03-20 | 0001140361-26-010591 | EDGAR | 15K words |
| 2026-01-15 | 0001140361-26-001268 | EDGAR | 1K words |
| 2025-12-23 | 0001140361-25-046546 | EDGAR | 1K words |
| 2025-12-18 | 0001140361-25-045950 | EDGAR | 1K words |
| 2025-11-14 | 0001140361-25-042304 | EDGAR | 3K words |
| 2025-11-10 | 0001140361-25-041293 | EDGAR | 1K words |
135 total filings indexed. 108 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001339005 |
| Ticker | FEMY |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.femasys.com |
| Listed | 2021-06-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/FEMY (~200 tokens, structured JSON with cryptographic provenance)